D. Harris

发表

Inhibitory and activators of cyclic nucleotide phosphodiesterase.

M. Chasin, D. Harris, 1976, Advances in cyclic nucleotide research.

Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs.

R. Vollmer, V. Murthy, D. Harris, 1978, European journal of pharmacology.

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.

B. Rubin, Z. Horovitz, R. Laffan, 1978, European journal of pharmacology.

Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs.

B. Rubin, R. Laffan, M. E. Goldberg, 1978, European journal of pharmacology.

Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.

B. Rubin, Z. Horovitz, R. Laffan, 1979, Japanese journal of pharmacology.

Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.

O. Kocy, J. Barrish, R. Misra, 1993, Journal of medicinal chemistry.

1-Ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)--a potent new inhibitor of cyclic 3',5'-nucleotide phosphodiesterases.

S. Hess, M. Chasin, D. Harris, 1972, Biochemical pharmacology.

Effects of therapeutic agents on cyclic AMP metabolism in vitro.

C. Free, S. Hess, M. Chasin, 1972, Journal of pharmaceutical sciences.

DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors.

E. Liu, M. Webb, D. Harris, 1992, Prostaglandins.

Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

M. Ogletree, D. Harris, R. Greenberg, 1985, The Journal of pharmacology and experimental therapeutics.

Sympathoadrenal and Renin‐Angiotensin Systems in the Development of Two‐Kidney, One Clip Renal Hypertension in Rats

B. Rubin, M. Waugh, D. Harris, 1980, Hypertension.

Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.

M. Webb, R. Misra, M. Ogletree, 1993, The Journal of pharmacology and experimental therapeutics.

Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chains.

M. Webb, R. Misra, W. Han, 1991, Journal of medicinal chemistry.

Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle.

D. Harris, T. Steinbacher, H. Goldenberg, 1984, European journal of pharmacology.

9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor.

P. Sprague, M. Antonaccio, D. Harris, 1981, Prostaglandins.

Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.

J. Fried, M. Antonaccio, D. Harris, 1981, Thrombosis research.

Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys.

M. Ogletree, D. Harris, W. Schumacher, 1989, The American journal of physiology.

Chapter 23. Agents Affecting Cyclic AMP Levels

S. Hess, D. Harris, N. S. Semenuk, 1973 .

9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase.

W. Han, S. Hall, M. Ogletree, 1986, Journal of medicinal chemistry.

Thromboxane receptor antagonist BMS-180291: A new pre-clinical lead

J. Barrish, P. Sprague, R. Morrison, 1992 .

Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.

J. Das, M. Ogletree, D. Harris, 1988, Journal of medicinal chemistry.

7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza omega-chain analogues.

J. Das, W. Han, M. Ogletree, 1990, Journal of medicinal chemistry.

Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.

P. Sprague, D. Harris, M. Malley, 1985, Journal of medicinal chemistry.

Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.

M. Antonaccio, D. Harris, H. Goldenberg, 1979, Journal of cyclic nucleotide research.

Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.

E. Liu, S. Hall, M. Ogletree, 1988, The Journal of pharmacology and experimental therapeutics.

Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey.

M. Ogletree, D. Harris, W. Schumacher, 1987, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analog.

S. Hall, M. Ogletree, D. Harris, 1986, Prostaglandins.

Thromboxane receptor antagonist properties of SQ 27,427 in the anesthetized guinea pig.

D. Harris, T. Steinbacher, R. Greenberg, 1984, European journal of pharmacology.

Effect of SQ 80,338 (1-(3-phenyl-2-propenyl)-1H-imidazole) on thromboxane synthetase activity and arachidonic acid-induced platelet aggregation and bronchoconstriction.

M. Antonaccio, D. Harris, M. Phillips, 1980, Advances in prostaglandin and thromboxane research.

Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.

E. Liu, M. Webb, R. Misra, 1993, The Journal of pharmacology and experimental therapeutics.

Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.

P. Sprague, D. Harris, R. Greenberg, 1980, Advances in prostaglandin and thromboxane research.

Thoromboxane A2/endoperoxide receptor antagonists: 1,3-Dioxane and 1,3-dioxolane analogs

M. Webb, J. Das, H. Monshizadegan, 1993 .

Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.

S. Hess, M. Chasin, D. Harris, 1973, Biochemical Pharmacology.